IFPA understands global concern regarding Coronavirus (COVID-19). In the face of this pandemic, it is our mission to collect and deliver the most credible and reliable information regarding psoriasis and COVID-19. We invite you to explore our dedicated pages for guidance in navigating these uncertain times.
Tell your story!
Do you have psoriasis or psoriatic arthritis? Are you a family of friend of someone who does? We want to hear about how the COVID-19 pandemic has impacted you. Share your story through IFPA’s social media. Your experience can be a comfort to others during this difficult time. Click here to share your story!
PsoProtect and PsoProtectMe
IFPA is pleased to partner with PsoProtect and PsoProtectMe.
PsoProtect is an international registry for healthcare providers to report outcomes of COVID-19 in individuals with psoriasis. At the same time, PsoProtectMe is collecting self-reported data from people living with psoriasis through the COVID-19 pandemic. The results will help us better understand how the COVID-19 pandemic is affecting people with psoriasis, and which clinical recommendations might be helpful.
IFPA highly encourages everyone who has psoriasis, whether or not you have experienced symptoms of COVID-19, to respond to the PsoProtectMe survey.
Respond to the survey and learn more at:
IFPA has prepared an advocacy toolkit that uses the World Health Organization’s Resolution on COVID-19 Response to position psoriasis and psoriatic arthritis within the global discussion surrounding crisis response. People living with diseases like psoriasis and psoriatic arthritis are vulnerable in a pandemic. We must be prepared to meet their needs even in critical times. View the toolkit to learn how you can make a difference.
The IFPA Quarterly Newsletter: COVID-19 Edition is out now! Discover an array of topics that examine the relationship between psoriasis, psoriatic arthritis, and COVID-19 from every angle.
You are invited to share these images on your social media. Click the image to download it.